Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1976 Jul;49(3):199–203.

Viral hepatitis: overview and historical perspectives.

S Krugman
PMCID: PMC2595355  PMID: 785825

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLUMBERG B. S., ALTER H. J., VISNICH S. A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965 Feb 15;191:541–546. doi: 10.1001/jama.1965.03080070025007. [DOI] [PubMed] [Google Scholar]
  2. Blumberg B. S., Gerstley B. J., Hungerford D. A., London W. T., Sutnick A. I. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med. 1967 May;66(5):924–931. doi: 10.7326/0003-4819-66-5-924. [DOI] [PubMed] [Google Scholar]
  3. KRUGMAN S., WARD R., GILES J. P., JACOBS A. M. Infectious hepatitis. Studies on the effect of gamma globulin and on the incidence of inapparent infection. JAMA. 1960 Oct 15;174:823–830. doi: 10.1001/jama.1960.03030070001001. [DOI] [PubMed] [Google Scholar]
  4. KRUGMAN S., WARD R., GILES J. P. The natural history of infectious hepatitis. Am J Med. 1962 May;32:717–728. doi: 10.1016/0002-9343(62)90161-4. [DOI] [PubMed] [Google Scholar]
  5. KRUGMAN S., WARD R. Infectious hepatitis: current status of prevention with gamma globulin. Yale J Biol Med. 1961 Dec;34:329–339. [PMC free article] [PubMed] [Google Scholar]
  6. Krugman S., Giles J. P., Hammond J. Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains. J Infect Dis. 1970 Nov;122(5):432–436. doi: 10.1093/infdis/122.5.432. [DOI] [PubMed] [Google Scholar]
  7. Krugman S., Giles J. P., Hammond J. Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA. 1967 May 1;200(5):365–373. doi: 10.1001/jama.200.5.365. [DOI] [PubMed] [Google Scholar]
  8. Krugman S., Giles J. P. Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention. N Engl J Med. 1973 Apr 12;288(15):755–760. doi: 10.1056/NEJM197304122881503. [DOI] [PubMed] [Google Scholar]
  9. Krugman S., Giles J. P. Viral hepatitis. New light on an old disease. JAMA. 1970 May 11;212(6):1019–1029. doi: 10.1001/jama.212.6.1019. [DOI] [PubMed] [Google Scholar]
  10. MacCallum F. O. 1971 International Symposium on Viral Hepatitis. Historical perspectives. Can Med Assoc J. 1972 Feb 26;106(Suppl):423–426. [PMC free article] [PubMed] [Google Scholar]
  11. RIGHTSEL W. A., KELTSCH R. A., TEKUSHAN F. M., MCLEAN I. W., Jr Tissue-culture cultivation of cytopathogenic agents from patients with clinical hepatitis. Science. 1956 Aug 3;124(3214):226–228. doi: 10.1126/science.124.3214.226. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES